Robert Coffey

Has grant

Professor

Vanderbilt University Medical Center
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Coffey is a Professor at Vanderbilt University Medical Center in the United States. His research focuses on extracellular vesicles and nanoparticles, investigating their roles in various diseases including glioblastoma and colorectal cancer. Recent articles by Professor Coffey delve into the complexities of these biological entities, their isolation methods, and their impact on cell signaling and regeneration processes.

Recent Grants

Grant: Close

Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma

Open Date: 2019-07-15

Close Date: 2021-06-30

Grant: Close

Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer

Open Date: 2019-07-09

Close Date: 2024-06-30

Grant: Close

Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation

Open Date: 2018-09-20

Close Date: 2023-06-30

Grant: Close

Integrated approach to study early and late events in colonic neoplasia: mouse to man

Open Date: 2017-04-01

Close Date: 2024-03-31

Grant: Close

Spatio-temporal dissection of epithelial cell hierarchies in gut inflammation

Open Date: 2014-07-01

Close Date: 2017-06-30

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

With each breath, oxygen diffuses across remarkably thin alveolar type I (AT1) cells into underlying capillaries. Interspersed cuboidal AT2 cells produce surfactant and act as stem cells. Even transient disruption of this delicate barrier can promote capillary leak. Here, we selectively ablated AT1 cells, which uncovered rapid AT2 cell flattening with near-continuous barrier preservation, culminating in AT1 differentiation. Proliferation subsequently restored depleted AT2 cells in two phases, mitosis of binucleated AT2 cells followed by replication of mononucleated AT2 cells. M phase entry of binucleated and S phase entry of mononucleated cells were both triggered by AT1-produced hbEGF signaling via EGFR to Wnt-active AT2 cells. Repeated AT1 cell killing elicited exuberant AT2 proliferation, generating aberrant daughter cells that ceased surfactant function yet failed to achieve AT1 differentiation. This hyperplasia eventually resolved, yielding normal-appearing alveoli. Overall, this specialized regenerative program confers a delicate simple epithelium with functional resiliency on par with the physical durability of thicker, pseudostratified, or stratified epithelia.

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Bhuminder Singh

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Tushar J. Desai

-

UNITED STATES
View details

Dennis Jeppesen

Assistant Professor

Vanderbilt University School of Medicine

UNITED STATES
View details

Yu Shyr

Professor and Chair

Vanderbilt University Medical Center

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.